Johnson & Johnson (JNJ) Change in Acquisitions & Divestments (2009 - 2026)

Johnson & Johnson (JNJ) posted Change in Acquisitions & Divestments of $209.0 million for Q1 2026, down 4.57% sequentially from $219.0 million in Q4 2025, and down 4.13% YoY from $218.0 million in Q1 2025.

Johnson & Johnson (JNJ) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Change in Acquisitions & Divestments data on file, last reported at $209.0 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 4.13% year-over-year to $209.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 2.88% YoY) and the FY2025 annual result came in at $1.7 billion, down 32.53% from the prior year.
  • Change in Acquisitions & Divestments fell to $209.0 million in Q1 2026 per JNJ's latest filing, from $219.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $24.8 billion in Q1 2023, with the low at $209.0 million in Q1 2026.
  • Average Change in Acquisitions & Divestments over 5 years is $3.7 billion, with a median of $735.0 million recorded in 2025.
  • Year-over-year, Change in Acquisitions & Divestments gained 23.21% in 2023 and sank 91.95% in 2024.
  • Johnson & Johnson's Change in Acquisitions & Divestments stood at $6.3 billion in 2022, then slumped by 42.84% to $3.6 billion in 2023, then slumped by 91.95% to $290.0 million in 2024, then retreated by 24.48% to $219.0 million in 2025, then decreased by 4.57% to $209.0 million in 2026.
  • Business Quant data shows JNJ's Change in Acquisitions & Divestments at $209.0 million in Q1 2026, $219.0 million in Q4 2025, and $489.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 209.00 Mn
Mar 29, 2026 209.00 Mn
Dec 28, 2025 219.00 Mn
Dec 28, 2025 219.00 Mn
Sep 28, 2025 489.00 Mn
Sep 28, 2025 489.00 Mn
Jun 29, 2025 735.00 Mn
Jun 29, 2025 735.00 Mn
Mar 30, 2025 218.00 Mn
Mar 30, 2025 218.00 Mn
Dec 29, 2024 290.00 Mn
Dec 29, 2024 290.00 Mn
Sep 29, 2024 466.00 Mn
Sep 29, 2024 466.00 Mn
Jun 30, 2024 727.00 Mn
Jun 30, 2024 727.00 Mn
Mar 31, 2024 979.00 Mn
Mar 31, 2024 979.00 Mn
Dec 31, 2023 3.60 Bn
Dec 31, 2023 3.60 Bn